These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22868929)

  • 41. Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo.
    Zhu H; Liang ZY; Ren XY; Liu TH
    Cancer Biol Ther; 2006 Dec; 5(12):1693-8. PubMed ID: 17106254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control.
    Luo S; Zhao J; Fowdur M; Wang K; Jiang T; He M
    Sci Rep; 2016 Nov; 6():37690. PubMed ID: 27883047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.
    Sunaga N; Shames DS; Girard L; Peyton M; Larsen JE; Imai H; Soh J; Sato M; Yanagitani N; Kaira K; Xie Y; Gazdar AF; Mori M; Minna JD
    Mol Cancer Ther; 2011 Feb; 10(2):336-46. PubMed ID: 21306997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis.
    Cui X; Liu Y; Wang B; Xian G; Liu X; Tian X; Qin C
    Biotechnol Appl Biochem; 2015; 62(6):861-7. PubMed ID: 25471990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.
    Hubbard K; Catalano J; Puri RK; Gnatt A
    BMC Cancer; 2008 May; 8():133. PubMed ID: 18474089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.
    Hu P; Chen X; Sun J; Bie P; Zhang LD
    Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25370920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
    Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
    BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silencing of the Smad nuclear interacting protein 1 (SNIP1) by siRNA inhibits proliferation and induces apoptosis in pituitary adenoma cells.
    Chen X; Xue F; Xie T; Luo C
    Tumour Biol; 2013 Oct; 34(5):3071-6. PubMed ID: 23897559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1.
    Chen LM; Le HY; Qin RY; Kumar M; Du ZY; Xia RJ; Deng J
    World J Gastroenterol; 2005 Feb; 11(6):831-8. PubMed ID: 15682475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways.
    Gu Z; Lin C; Hu J; Xia J; Wei S; Gao D
    Biol Pharm Bull; 2019 Apr; 42(4):573-579. PubMed ID: 30686807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
    Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
    Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.
    Heminger K; Markey M; Mpagi M; Berberich SJ
    Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
    Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
    Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of nasopharyngeal carcinoma cell line C666-1 in vitro.
    Ying X; Zhang R; Wang H; Teng Y
    Gene; 2014 May; 542(1):77-82. PubMed ID: 24630965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
    Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
    Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
    J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
    Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
    Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
    Terado T; Kim CJ; Ushio A; Minami K; Tambe Y; Kageyama S; Kawauchi A; Tsunoda T; Shirasawa S; Tanaka H; Inoue H
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
    Li T; Lu J; Zhong Y
    J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
    Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
    Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.